112 related articles for article (PubMed ID: 16095053)
21. High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study.
Ostrowski SR; Sørensen AM; Windeløv NA; Perner A; Welling KL; Wanscher M; Larsen CF; Johansson PI
Scand J Trauma Resusc Emerg Med; 2012 Apr; 20():27. PubMed ID: 22490186
[TBL] [Abstract][Full Text] [Related]
22. The interplay between c-Myc oncogene expression and circulating vascular endothelial growth factor (sVEGF), its antagonist receptor, soluble Flt-1 in diffuse large B cell lymphoma (DLBCL): relationship to patient outcome.
Aref S; Mabed M; Zalata K; Sakrana M; El Askalany H
Leuk Lymphoma; 2004 Mar; 45(3):499-506. PubMed ID: 15160911
[TBL] [Abstract][Full Text] [Related]
23. A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.
Wu FT; Stefanini MO; Mac Gabhann F; Popel AS
PLoS One; 2009; 4(4):e5108. PubMed ID: 19352513
[TBL] [Abstract][Full Text] [Related]
24. Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport.
Wu FT; Stefanini MO; Mac Gabhann F; Kontos CD; Annex BH; Popel AS
Physiol Genomics; 2009 Jun; 38(1):29-41. PubMed ID: 19351908
[TBL] [Abstract][Full Text] [Related]
25. Disruption of components of vascular endothelial growth factor angiogenic signalling system in metabolic syndrome. Findings from a study conducted in rural Bangladeshi women.
Jesmin S; Akter S; Rahman MM; Islam MM; Islam AM; Sultana SN; Mowa CN; Yamaguchi N; Okazaki O; Satoru K; Kimura S; Hiroe M; Mizutani T; Moroi M
Thromb Haemost; 2013 Apr; 109(4):696-705. PubMed ID: 23364276
[TBL] [Abstract][Full Text] [Related]
26. Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase.
Sela S; Natanson-Yaron S; Zcharia E; Vlodavsky I; Yagel S; Keshet E
Circ Res; 2011 Apr; 108(9):1063-70. PubMed ID: 21415391
[TBL] [Abstract][Full Text] [Related]
27. Circulating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancer.
Kuemmel S; Thomas A; Landt S; Fuger A; Schmid P; Kriner M; Blohmer JU; Sehouli J; Schaller G; Lichtenegger W; Köninger A; Fuchs I
Anticancer Res; 2009 Feb; 29(2):641-5. PubMed ID: 19331214
[TBL] [Abstract][Full Text] [Related]
28. Increased plasma concentration of vascular endothelial growth factor in patients with atopic dermatitis and its relation to disease severity and platelet activation.
Koczy-Baron E; Jochem J; Kasperska-Zajac A
Inflamm Res; 2012 Dec; 61(12):1405-9. PubMed ID: 22915086
[TBL] [Abstract][Full Text] [Related]
29. [Circulating VEGF and its soluble receptor sVEGFR-1 in patients with lung cancer].
Swidzińska E; Ossolińska M; Naumnik W; Izycki T; Kucejko W; Chyczewska E
Pneumonol Alergol Pol; 2004; 72(9-10):389-94. PubMed ID: 16021992
[TBL] [Abstract][Full Text] [Related]
30. Soluble VEGFR1 (sVEGFR1) as a novel marker of amyotrophic lateral sclerosis (ALS) in the North Indian ALS patients.
Anand A; Gupta PK; Sharma NK; Prabhakar S
Eur J Neurol; 2012 May; 19(5):788-92. PubMed ID: 21978169
[TBL] [Abstract][Full Text] [Related]
31. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study.
Sunderji S; Gaziano E; Wothe D; Rogers LC; Sibai B; Karumanchi SA; Hodges-Savola C
Am J Obstet Gynecol; 2010 Jan; 202(1):40.e1-7. PubMed ID: 19762001
[TBL] [Abstract][Full Text] [Related]
32. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of serum levels of vascular endothelial growth factor and its receptor in biliary disease and carcinoma.
Enjoji M; Nakamuta M; Yamaguchi K; Ohta S; Kotoh K; Fukushima M; Kuniyoshi M; Yamada T; Tanaka M; Nawata H
World J Gastroenterol; 2005 Feb; 11(8):1167-71. PubMed ID: 15754398
[TBL] [Abstract][Full Text] [Related]
34. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
35. Soluble receptors for vascular endothelial growth factor (sVEGFR1/sVEGFR2) in infantile hemangioma.
Przewratil P; Sitkiewicz A; Andrzejewska E
Growth Factors; 2010 Dec; 28(6):417-25. PubMed ID: 20854187
[TBL] [Abstract][Full Text] [Related]
36. Selected angiogenic cytokines in systemic lupus erythematosus patients.
Hrycek A; Janowska J; Cieślik P
Autoimmunity; 2009 Aug; 42(5):459-66. PubMed ID: 19811263
[TBL] [Abstract][Full Text] [Related]
37. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
[TBL] [Abstract][Full Text] [Related]
38. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Med Wieku Rozwoj; 2008; 12(1):499-506. PubMed ID: 18663270
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
Oehler MK; Caffier H
Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678
[TBL] [Abstract][Full Text] [Related]
40. Autologous stem cell transplantation: leukapheresis product has anti-angiogenic effects in vivo correlating with neutrophil-derived VEGFR1.
Luethy A; Stenner F; Lohri C; Muller C; Samaras P; Steiner R; Van Den Broek M; Mischo A; Renner C; Knuth A; Ruegg C; Wenger RH; Zweifel M
Anticancer Res; 2011 Oct; 31(10):3115-24. PubMed ID: 21965716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
